NIH chief says comparative studies hold risk for personalized medicine

10/26/2009 | Reuters

The use of comparative-effectiveness research as a means to reduce health care costs could jeopardize the advances in personalized medicine because such studies tend to miss groups of people who might benefit from a particular treatment, NIH Director Dr. Francis Collins said. "We need to be mindful of the goal of comparative-effectiveness research and not lose all that we have gained in understanding how individuals differ and how that could be factored into better diagnostics and preventive strategies," Collins said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC